<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Journal of Medicinal Plants</title>
<title_fa>فصلنامه گياهان دارویی</title_fa>
<short_title>J. Med. Plants</short_title>
<subject>Medical Sciences</subject>
<web_url>http://jmp.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2717-204X</journal_id_issn>
<journal_id_issn_online>2717-2058</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/jmp</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1390</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2012</year>
	<month>2</month>
	<day>1</day>
</pubdate>
<volume>11</volume>
<number>41</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa>&lt;i&gt;Cynara scolymus&lt;/i&gt; L. in Treatment of Hypercholesterolemic Type 2 Diabetic Patients: a Randomized Double-Blind Placebo-Controlled Clinical Trial</title_fa>
	<title>&lt;i&gt;Cynara scolymus&lt;/i&gt; L. in Treatment of Hypercholesterolemic Type 2 Diabetic Patients: a Randomized Double-Blind Placebo-Controlled Clinical Trial</title>
	<subject_fa>فارماكولوژی و سم شناسی</subject_fa>
	<subject>Pharmacology &amp; Toxicology</subject>
	<content_type_fa>پژوهشی</content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Type 2 diabetes mellitus with hyperlipidemia is a common disease. Conventional anti-hyperglycemic and anti-hyperlipidemic drugs have limited efficacies and important side effects, so that alternative agents are needed. Previous studies suggest that fiber-free artichoke (&lt;em&gt;Cynara scolymus&lt;/em&gt; L.) leaf extract may have anti-hyperglycemic and anti-hypercholesterolemic effects in hypercholesterolemic type 2 diabetic patients. Moreover, artichoke leaves are used traditionally as an anti-hyperglycemic and anti-hyperlipidemic remedy to treat diabetes mellitus and hyperlipidemia. &lt;strong&gt;Objective:&lt;/strong&gt; The effects of artichoke leaf extract in treatment of hypercholesterolemic type 2 diabetic patients were studied. &lt;strong&gt;Methods: &lt;/strong&gt;In this randomized double-blind placebo-controlled clinical trial with hypercholesterolemic type 2 diabetic patients aged 40 to 60 years not using other anti-hyperlipidemic agents and resistant to daily intake of two 5 mg glyburide tablets and two 500 mg metformin tablets, the efficacy and safety of taking fiber-free artichoke leaf extract (one 400 mg capsule t.i.d. for 2 months) combined with the aforementioned drugs in treatment of 36 patients were evaluated and compared with the placebo group (n = 36). &lt;strong&gt;Results:&lt;/strong&gt; The extract lowered the blood levels of total cholesterol and LDL cholesterol significantly (P=0.002 and p=0.040 respectively) without any significant effects on the blood levels of fasting glucose, postprandial glucose, glycosylated hemoglobin, other lipids, SGOT, SGPT and creatinine (P&gt;0.05) compared with placebo at the endpoint. No adverse effects were reported. &lt;strong&gt;Conclusion:&lt;/strong&gt; Fiber-free artichoke extract may be a safe anti-hypercholesterolemic agent but does not improve glycemic control in hypercholesterolemic type 2 diabetic patients, suggesting the involvement of fibers in the anti-hyperglycemic effect of artichoke.&lt;/div&gt;</abstract_fa>
	<abstract>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Type 2 diabetes mellitus with hyperlipidemia is a common disease. Conventional anti-hyperglycemic and anti-hyperlipidemic drugs have limited efficacies and important side effects, so that alternative agents are needed. Previous studies suggest that fiber-free artichoke (&lt;em&gt;Cynara scolymus&lt;/em&gt; L.) leaf extract may have anti-hyperglycemic and anti-hypercholesterolemic effects in hypercholesterolemic type 2 diabetic patients. Moreover, artichoke leaves are used traditionally as an anti-hyperglycemic and anti-hyperlipidemic remedy to treat diabetes mellitus and hyperlipidemia. &lt;strong&gt;Objective:&lt;/strong&gt; The effects of artichoke leaf extract in treatment of hypercholesterolemic type 2 diabetic patients were studied. &lt;strong&gt;Methods: &lt;/strong&gt;In this randomized double-blind placebo-controlled clinical trial with hypercholesterolemic type 2 diabetic patients aged 40 to 60 years not using other anti-hyperlipidemic agents and resistant to daily intake of two 5 mg glyburide tablets and two 500 mg metformin tablets, the efficacy and safety of taking fiber-free artichoke leaf extract (one 400 mg capsule t.i.d. for 2 months) combined with the aforementioned drugs in treatment of 36 patients were evaluated and compared with the placebo group (n = 36). &lt;strong&gt;Results:&lt;/strong&gt; The extract lowered the blood levels of total cholesterol and LDL cholesterol significantly (P=0.002 and p=0.040 respectively) without any significant effects on the blood levels of fasting glucose, postprandial glucose, glycosylated hemoglobin, other lipids, SGOT, SGPT and creatinine (P&gt;0.05) compared with placebo at the endpoint. No adverse effects were reported. &lt;strong&gt;Conclusion:&lt;/strong&gt; Fiber-free artichoke extract may be a safe anti-hypercholesterolemic agent but does not improve glycemic control in hypercholesterolemic type 2 diabetic patients, suggesting the involvement of fibers in the anti-hyperglycemic effect of artichoke.&lt;/div&gt;</abstract>
	<keyword_fa>Artichoke, Hyperlipidemia, Patient, Type 2 diabetes</keyword_fa>
	<keyword>Artichoke, Hyperlipidemia, Patient, Type 2 diabetes</keyword>
	<start_page>58</start_page>
	<end_page>65</end_page>
	<web_url>http://jmp.ir/browse.php?a_code=A-10-71-6&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>H </first_name>
	<middle_name></middle_name>
	<last_name>Fallah Huseini </last_name>
	<suffix></suffix>
	<first_name_fa>H</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>Fallah Huseini</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460037145</code>
	<orcid>100319475328460037145</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Pharmacology and Applied Medicine, Institute of Medicinal Plants, ACECR</affiliation>
	<affiliation_fa>Department of Pharmacology and Applied Medicine, Institute of Medicinal Plants, ACECR</affiliation_fa>
	 </author>


	<author>
	<first_name>S </first_name>
	<middle_name></middle_name>
	<last_name>Kianbakht </last_name>
	<suffix></suffix>
	<first_name_fa>S</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>Kianbakht</last_name_fa>
	<suffix_fa></suffix_fa>
	<email>skianbakht@yahoo.com</email>
	<code>100319475328460037146</code>
	<orcid>100319475328460037146</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Pharmacology and Applied Medicine, Institute of Medicinal Plants, ACECR</affiliation>
	<affiliation_fa>Department of Pharmacology and Applied Medicine, Institute of Medicinal Plants, ACECR</affiliation_fa>
	 </author>


	<author>
	<first_name>R</first_name>
	<middle_name></middle_name>
	<last_name>Heshmat </last_name>
	<suffix></suffix>
	<first_name_fa>R</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>Heshmat</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460037147</code>
	<orcid>100319475328460037147</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Biostatistics and Epidemiology, Tehran University of Medical Sciences</affiliation>
	<affiliation_fa>Department of Biostatistics and Epidemiology, Tehran University of Medical Sciences</affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
